Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: J Mol Cell Cardiol. 2011 Nov 13;52(1):136–147. doi: 10.1016/j.yjmcc.2011.11.003

Figure 5. Increased SOCE activity and STIM1 levels in Ang II- or PE-treated cardiac myocytes in vitro.

Figure 5

(A) Quantitative real-time RT-PCR showing increased ANF mRNA levels in cultured neonatal cardiomyocytes exposed (48h) to Ang II (0.1 μM) and PE (50 μM). (B) Representative Ca2+ traces demonstrating SOCE in control, Ang II-, or PE-treated neonatal cardiomyocytes. Quantitative real-time RT-PCR analysis demonstrating increased STIM1 mRNA levels (C) and immunoblot-detected protein levels (D) in cultured neonatal cardiomyocytes treated with Ang II or PE.